Neogen Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Mikhael Nassif
- Full Time Employees
- 2,636
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 620 Lesher Place Lansing MI United States of America 48912-1595
- IPO Date
- Aug 23, 1989
- CIK
- 0000711377
- Website
- neogen.com
- Similar Companies
- Business
- Neogen Corporation (Nasdaq: NEOG), founded in 1982 and headquartered in Lansing, Michigan, develops, manufactures and markets comprehensive solutions for food and animal safety worldwide. The company operates through two primary segments: Food Safety, which offers diagnostic test kits including Reveal for Salmonella Enteritidis, Agri-Screen and Veratox for mycotoxins, NEO-GRID disposable filters, Molecular Detection Assay - Listeria Right Now for rapid Listeria species detection in environmental samples, and products to detect pathogens, toxins, allergens and contaminants in human and animal food; and Animal Safety, which provides veterinary pharmaceuticals, instruments, vaccines, topicals, rodenticides, cleaners, disinfectants, insecticides, genomics testing services for gene isolation, heredity mapping and breeding programs, and over 100 drug detection test kits for approximately 300 abused and therapeutic drugs in farm and racing animals. Neogen serves food manufacturers, processors, regulatory agencies, livestock producers, veterinarians, animal health companies, breeders, agricultural researchers and industries including agriculture and food production across more than 140 countries, with key operations in the United States, Canada, United Kingdom, Europe, Mexico, Brazil, India, China, Australia, Scotland and additional facilities in Kentucky, Wisconsin and Nebraska. In recent developments, Neogen completed the divestiture of its global cleaners and disinfectants business to Kersia Group in July 2025 for $130 million in cash plus contingent consideration, using net proceeds including $100 million to reduce debt and enhance focus on core diagnostics; appointed Mike Nassif as president and chief executive officer effective August 11, 2025, succeeding John Adent, alongside Bryan Riggsbee as chief financial officer in November 2025 and Avi Pelossof to the board in October 2025; formed a strategic partnership with Biomatter to develop AI-enabled enzyme-based products for food safety testing; renewed sponsorship with the United States Equestrian Federation in 2025 to advance equine botulism prevention education tied to its BotVax B vaccine; launched the Listeria Right Now molecular assay in 2025; and reaffirmed fiscal 2026 guidance of $820 million to $840 million in revenue and $165 million to $175 million in adjusted EBITDA following first-quarter results and restructuring with headcount reductions. The company resulted from the 2022 merger with 3M's food safety business, expanding its diagnostics portfolio and global presence.
Company News
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Neogen Corporation (NEOG) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Neogen Corporation (NASDAQ:NEOG) Stock Has Average Price Target of $12.67
3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Neogen Corporation: Promising Recurring Demand With Food Safety
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOG
Dow, Nasdaq Futures Down Triple Digits on Higher Oil, Yields
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
Neogen Corporation (NEOG) Analyst/Investor Day Transcript
Neogen (NEOG) Stock Declines Despite Strong Q1 Performance
Neogen Shifts Focus to Scale Profitable Growth
Neogen (NEOG) Securities Investigation Notice - Levi & Korsinsky
Neogen (NEOG) Securities Investigation Notice - Levi & Korsinsky
Rising Oil, Treasury Yields Pressure Stock Futures
What Neogen (NEOG) Said on Its Q1 Earnings Call
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics